Contribution of maternal-fetal adrenomedullin polymorphism to gestational hypertension and preeclampsia - Gene-gene interaction pilot study

Ginekologia Polska

Volumn 83, Issue 7, 2012, Pages 494-500

  Boć Zalewska, Adrianna ^a   Seremak Mrozikiewicz, Agnieszka ^a   Barlik, Magdalena ^a   Kurzawińska, Grazyna ^a   Drews, Krzysztof ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Adrenomedullin; Genetic polymorphism; Gestational hypertension; Preeclampsia

Indexed keywords

ADRENOMEDULLIN;

ADULT; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; FETOMATERNAL TRANSFUSION; GENETIC POLYMORPHISM; GENETICS; HUMAN; HYPERTENSION; MATERNAL HYPERTENSION; NEWBORN; PILOT STUDY; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; RISK FACTOR;

ADRENOMEDULLIN; ADULT; FEMALE; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PILOT PROJECTS; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; RISK FACTORS; YOUNG ADULT;

EID: 84865814433     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lopez J, Martinez A. Cell and molecular biology of the multifunctional peptide, adrenomedullin. Int Rev Cytol. 2002, 221, 1-92.
2. Hay D, Walker CS Poyner D. Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges. Endocr Relat Cancer. 2010, 13, 18-32.
3. Kato J, Tsuruda T, Kita T, [et al.]. Adrenomedullin: a protective factor for blood vessels. Arterioscler Thromb Vasc Biol. 2005, 25, 2480-2485.
4. Grill S, Rusterholz C, Zanetti-Dällenbach R, [et al.]. Potential markers of preeclampsia - a review. Reprod Biol Endocrinol. 2009, 7, 70-84.
5. Minegishi T, Nakamura M, Abe K. [et al.]. Adrenomedullin and atrial natriuretic peptide concentrations in normal pregnancy and preeclampsia. Mol Hum Reprod. 1999, 5, 767-770.
6. Kobayashi K, Kubota T, Aso T, [et al.]. Immunoreactive adrenomedullin (AN) concentration in maternal plasma during human pregnancy and AM expression in placenta. Eur J Endocrinol. 2000, 142, 683-687.
7. Cheung B, Ong K, Tso A, [et al.]. Plasma adrenomedullin level is related to a single nucleotide polymorphism in the adrenomedullin gene. Eur J Endocrinol. 2011, 165, 571-577.
8. Ishimitsu T, Ono H, Minami J, Matsuoka H. Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders. Pharmacol Ther. 2006, 111, 909-927.
9. Boć-Zalewska A, Seremak-Mrozikiewicz A, Barlik M, [et al.]. The possible role of adrenomedullin in the etiology of gestational hypertension and preeclampsia. Ginekol Pol. 2011, 82, 178-184.
10. Gratton R, Gluszynski M, Mazzuca D, [et al.]. Adrenomedullin messenger ribonucleic acid expression in the placentae of normal and preeclamptic pregnancies. J Clin Endocrinol Metab. 2003, 88, 6048-6055.
11. Lauria M, Standley C, Sorokin Y, [et al.]. Adrenomedullin levels in normal and preeclamptic pregnancy at term. J Soc Gynecol Investig. 1999, 6, 318-321.
12. Di Iorio R, Marinoni E, Letizia C, [et al.]. Adrenomedullin, a new vasoactive peptide, is increased in preeclampsia. Hypertension. 1998, 32, 758-763.
13. Hata T, Miyazaki K, Matsui K. Decreased circulating adrenomedullin in pre-eclampsia. Lancet. 1997, 350, 1600-1605.
14. Nakazawa I, Nakajima T, Harada H, [et al.]. Human calcitonin receptor-like receptor for adrenomedullin: genomic structure, eight single-nucleotide polymorphisms and haplotype analysis. J Hum Genet. 2001, 46, 132-136.
15. Li Y, Staessen J, Li L, [et al.]. Blood pressure and urinary sodium excretion in relation to the A-1984G adrenomedullin polymorphism in a Chinese population. Kidney Int. 2006, 69, 1153-1158.
16. Kosmas I, Tatsioni A, Joannidis J. Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens. 2003, 21, 1221-1228.
17. Lachmeijer A, Arngrimsson R, Bastiaans E. Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels and vitamins status in women with a history of pre-eclampsia. Am J Obstet Gynecol. 2001, 184, 394-402.
18. Morgan L, Crawshaw S, Baker P. Maternal and fetal angiotensinogen gene allele sharing in pre-eclampsia. Br J Obstet Gynecol. 1999, 106, 244-251.
19. Pridjian G, Puschett J. Preeclampsia: Part 2 experimental and genetic considerations. Obstet Gynecol Surv. 2002, 57, 619-640.
20. Wilson M, Desmond D, Goodwin T, [et al.]. Maternal and fetal variants in the TGF-beta3 gene and risk of pregnancy-induced hypertension in a predominantly latino population. Am J Obstet Gynecol. 2009, 201, 295-300.
21. Hill L, York T, Kusanovic J, [et al.]. Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia. PLoS One. 2011, 6, 16681.
22. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005, 365, 785-799.
23. Nejatizadeh A, Stobdan T, Malhotra N, [et al.]. The genetic aspects of pre-eclampsia: achievements and limitations. Biochem Genet. 2008, 46, 451-479.
24. Hinson J, Kapas S, Smith D. Adrenomedullin, a multifunctional regulatorypeptide. Endocr Rev. 2000, 21, 138-167.
25. Kato J, Kitamura K, Eto T. Plasma adrenomedullin level and development of hypertension. J Hum Hypertens. 2006, 20, 566-570.